Oh crikey @ralom - wouldn't buy the blessed things. Just thought they looked like they might have a bit of a bounce but if New York doesn't keep going, they will fail again.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025